Literature DB >> 34049551

Oral contraceptives and hypertension in women: results of the enrolment phase of Tabari Cohort Study.

Mahdi Afshari1, Reza Alizadeh-Navaei2, Mahmood Moosazadeh3.   

Abstract

BACKGROUND: The association between oral contraceptives (OCP) and hypertension has been reported in the literature with controversial results. According to the growing use of OCPs among women in Iran, this study aims to investigate the association between the duration of the OCP consumption and risk of hypertension among Iranian women.
METHODS: In the current study, the data collected during the enrolment phase of the Tabari cohort were analyzed. Of 6106 women recruited in the cohort, 133 pregnant women were excluded. Epidemiological variables were collected using pre-designed questionnaires as well as the health insurance evidences. In addition, blood pressure and anthropometric factors were measured based on the standard guidelines. Chi square and partial correlation tests as well as logistic regression models were applied for data analysis.
RESULTS: Frequency of oral contraceptive use among 35-70 year-old women in Tabari cohort study (TCS) was 42.2% (2520/5973). Hypertension was observed among 25% (1793/5973) of them. The adjusted odds ratio for OCP use was 1.23 (95% confidence interval: 1.08, 1.40, p = 0.002). The corresponding odds ratios for 61-120 months and more than 120 months OCP use were 1.39 (1.12,1.73) and 1.47 (1.16,1.87) respectively.
CONCLUSIONS: Oral contraceptives especially in long term use can be associated with hypertension.

Entities:  

Keywords:  Blood pressure; Diastole; Oral contraceptive; Systole

Year:  2021        PMID: 34049551     DOI: 10.1186/s12905-021-01376-4

Source DB:  PubMed          Journal:  BMC Womens Health        ISSN: 1472-6874            Impact factor:   2.809


  4 in total

Review 1.  Oral contraceptives and hypertension.

Authors:  J W Woods
Journal:  Hypertension       Date:  1988-03       Impact factor: 10.190

2.  Tabari Cohort Profile and Preliminary Results in Urban Areas and Mountainous Regions of Mazandaran, Iran.

Authors:  Motahareh Kheradmand; Mahmood Moosazadeh; Majid Saeedi; Hossein Poustchi; Sareh Eghtesad; Ravanbakhsh Esmaeili; Reza Alizadeh-Navaei; Akbar Hedayatizadeh-Omran; Roja Nikaeein; Alireza Rafiei; Ghasem Janbabaee; Zahra Kashi; Mehrnoush Sohrab; Mahboobeh Shirzad AhooDashti; Mahdi Afshari; Bahareh Golpour; Mohsen Aarabi; Iradj Maleki; Hafez Tirgar Fakheri; Ali Ghaemian; Mehran Zarghami; Alireza Ghaemi
Journal:  Arch Iran Med       Date:  2019-06-01       Impact factor: 1.354

Review 3.  Epidemiology and heterogeneity of hypertension in Iran: a systematic review.

Authors:  Ali-Akbar Haghdoost; Behnam Sadeghirad; Mohammad Rezazadehkermani
Journal:  Arch Iran Med       Date:  2008-07       Impact factor: 1.354

4.  The PERSIAN Cohort: Providing the Evidence Needed for Healthcare Reform.

Authors:  Sareh Eghtesad; Zahra Mohammadi; Amaneh Shayanrad; Elnaz Faramarzi; Farahnaz Joukar; Behrooz Hamzeh; Mojtaba Farjam; Mohammad Javad Zare Sakhvidi; Mohammadreza Miri-Monjar; Mahmood Moosazadeh; Hamid Hakimi; Salar Rahimi Kazerooni; Bahman Cheraghian; Ali Ahmadi; Azim Nejatizadeh; Iraj Mohebbi; Farhad Pourfarzi; Farzin Roozafzai; Nazgol Motamed-Gorji; Seyed Ali Montazeri; Sahar Masoudi; Masoumeh Amin-Esmaeili; Navid Danaie; Seyed Reza Mirhafez; Hasan Hashemi; Hossein Poustchi; Reza Malekzadeh
Journal:  Arch Iran Med       Date:  2017-11-01       Impact factor: 1.354

  4 in total
  2 in total

1.  Pattern of contraceptive use among reproductive-aged women with diabetes and/or hypertension: findings from Bangladesh Demographic and Health Survey.

Authors:  Md Nuruzzaman Khan; M Mofizul Islam; Rakibul M Islam
Journal:  BMC Womens Health       Date:  2022-06-15       Impact factor: 2.742

Review 2.  Hypertension in Women.

Authors:  Tatjana Tasić; Marijana Tadić; Maja Lozić
Journal:  Front Cardiovasc Med       Date:  2022-06-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.